Narendra Chirmule

Narendra Chirmule is a director at SymphonyTech, a data analytics company focused on engineering solutions for biology. As former Head of R&D at Biocon (Bangalore), and in leadership positions at Amgen (Thousand Oaks, CA) and Merck Vaccines (West Point, PA), he has contributed to the clinical development of vaccines, biologics, and cell-and-gene therapies.

During his academic career, he has worked on the development of a leprosy vaccine, the pathogenesis of AIDS, and gene therapy for several rare diseases. Dr. Chirmule is on the NIH advisory committee for HIV vaccines. He is a TEDx speaker and recently published a book “Good Genes Gone Bad” by Penguin Press, both of which describe lessons learned from colossal failures in drug development.